Human Multipotent Adult Progenitor Cells Effectively Reduce GVHD While Preserving Graft-Versus-Leukemia Activity after Allogeneic BMT

被引：0
|
作者：
Metheny, Leland [1 ]
机构：
[1] Univ Hosp Cleveland, Cleveland, OH 44106 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2014年 / 14卷
关键词：
D O I：
10.1016/j.clml.2014.06.104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
906
引用
收藏
页码：S158 / S158
页数：1
相关论文
共 50 条
  • [31] Regulatory B cells promote graft-versus-host disease prevention and maintain graft-versus-leukemia activity following allogeneic bone marrow transplantation
    Hu, Yue
    He, Gan-Lin
    Zhao, Xiang-Yu
    Zhao, Xiao-Su
    Wang, Yu
    Xu, Lan-Ping
    Zhang, Xiao-Hui
    Yu, Xue-Zhong
    Liu, Kai-Yan
    Chang, Ying-Jun
    Huang, Xiao-Jun
    ONCOIMMUNOLOGY, 2017, 6 (03):
  • [32] Regulatory B cells promote graft-versus-host disease prevention and maintain graft-versus-leukemia activity following allogeneic bone marrow transplantation
    Hu, Y.
    He, G-L
    Zhao, X-Y
    Zhao, X-S
    Wang, Y.
    Xu, L-P
    Zhang, X-H
    Yu, X-Z
    Liu, K-Y
    Chang, Y-J
    Huang, X-J
    BONE MARROW TRANSPLANTATION, 2017, 52 : S48 - S49
  • [33] Preservation of graft-versus-leukemia activity after CD8 depleted allogeneic peripheral blood cell transplantation.
    Soiffer, RJ
    Kim, HT
    Hochberg, EP
    Ho, V
    Cutler, C
    Lee, SJ
    Fisher, DC
    Alyea, EP
    Antin, JH
    BLOOD, 2003, 102 (11) : 964A - 965A
  • [34] THE ROLE OF PURIFIED CD8(+) T-CELLS IN GRAFT-VERSUS-LEUKEMIA ACTIVITY AND ENGRAFTMENT AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    PALATHUMPAT, V
    DEJBAKHSHJONES, S
    STROBER, S
    TRANSPLANTATION, 1995, 60 (04) : 355 - 361
  • [35] Graft-versus-leukemia (GVL) effect and immune tolerance after donor leukocyte infusions for recurrence of chronic myeloid leukemia (CML) post allogeneic blood and marrow transplant (BMT)
    Michallet, M
    Moullet, I
    Gebuhrer, L
    Javaux, F
    Charrin, C
    Gabert, J
    Archimbaud, E
    Fiere, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1343 - 1343
  • [36] Deletion of AMP-Activated Protein Kinase (AMPK) in Donor T Cells Protects Against Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Responses
    Beezhold, Kevin
    Moore, Nathan
    Chiaranunt, Pailin
    Brown, Rebecca
    Byersdorfer, Craig Alan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S80 - S80
  • [37] IFN-γ promotes graft-versus-leukemia effects without directly interacting with leukemia cells in mice after allogeneic hematopoietic cell transplantation
    Yang, Yanping
    Wang, Hui
    Yu, Hui
    Yeap, Beow Yong
    Liang, Tingting
    Wang, Guanjun
    Cheng, Tao
    Yang, Yong-Guang
    BLOOD, 2011, 118 (13) : 3721 - 3724
  • [38] Do human leukocyte antigen E polymorphisms influence graft-versus-leukemia after allogeneic hematopoietic stem cell transplantation?
    Hosseini, Ehteramolsadat
    Schwarer, Anthony P.
    Ghasemzadeh, Mehran
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (03) : 149 - 157
  • [39] Bendamustine with total body irradiation conditioning yields tolerant T-cells while preserving T-cell-dependent graft-versus-leukemia
    Stokes, Jessica
    Hoffman, Emely A.
    Molina, Megan S.
    Kummet, Nicole
    Simpson, Richard J.
    Zeng, Yi
    Katsanis, Emmanuel
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [40] DISCONTINUATION OF CYCLOSPORINE (CSP) TO INDUCE A GRAFT-VERSUS-LEUKEMIA (GVL) EFFECT IN PATIENTS WITH CYTOGENETIC RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML)
    FLOWERS, MED
    CLIFT, R
    SCHOCH, G
    SULLIVAN, K
    MARTIN, P
    BLOOD, 1994, 84 (10) : A540 - A540
12345